Notably, TP53 (70.59%), RTK/RAS (37.25%), PI3K (33.33%), HIPPO (31.37%), and NOTCH (25.49%) pathways were frequently altered in gliomas. This evidence concerns the gene TP53 and central nervous system cancer.